Biological Responses of Human Bone Marrow Mesenchymal Stem Cells to Sr-M-Si (M = Zn, Mg) Silicate Bioceramics
Overview
Affiliations
Strontium (Sr), Zinc (Zn), magnesium (Mg), and silicon (Si) are reported to be essential trace elements for the growth and mineralization of bone. We speculated that the combination of these bioactive elements in bioceramics may be effective to regulate the osteogenic property of bone-forming cells. In this study, two Sr-containing silicate bioceramics, Sr(2)ZnSi(2)O(7) (SZS) and Sr(2)MgSi(2)O(7) (SMS), were prepared. The biological response of human bone marrow mesenchymal stem cells (BMSCs) to the two bioceramics (in the forms of powders and dense ceramic bulks) was systematically studied. In powder form, the effect of powder extracts on the viability and alkaline phosphatase (ALP) activity of BMSCs was investigated. In ceramic disc form, both direct and indirect coculture of BMSCs with ceramic discs were used to investigate their biological response, including attachment, proliferation, ALP activity, and bone-related genes expression. Beta-tricalcium phosphate (β-TCP) and akermanite (Ca(2)MgSi(2)O(7), CMS) were used as control materials. The results showed that the Sr, Zn, and Si (or Sr, Mg, and Si)-containing ionic products from SZS and SMS powders enhanced ALP activity of BMSCs, compared to those from β-TCP. Both SZS and SMS ceramic discs supported the growth of BMSCs, and most importantly, significantly enhanced the ALP activity and bone-related genes expression of BMSCs as compared to β-TCP. The results suggest that the specific combination of bioactive ions (Sr, Zn, Si, e.g.) in bioceramics is a viable way to improve the biological performance of biomaterials, and the form of materials and surface properties were nonnegligible factors to influence cell response.
The Role of Bioceramics for Bone Regeneration: History, Mechanisms, and Future Perspectives.
Tanvir M, Khaleque M, Kim G, Yoo W, Kim Y Biomimetics (Basel). 2024; 9(4).
PMID: 38667241 PMC: 11048714. DOI: 10.3390/biomimetics9040230.
Limitations and modifications in the clinical application of calcium sulfate.
Lun D, Li S, Li N, Mou L, Li H, Zhu W Front Surg. 2024; 11:1278421.
PMID: 38486794 PMC: 10937423. DOI: 10.3389/fsurg.2024.1278421.
Chen X, Li H, Ma Y, Jiang Y Molecules. 2023; 28(12).
PMID: 37375345 PMC: 10302440. DOI: 10.3390/molecules28124790.
Hosseinpour S, Dai H, Walsh L, Xu C Nanomaterials (Basel). 2023; 13(11).
PMID: 37299658 PMC: 10254425. DOI: 10.3390/nano13111755.
Existing and Novel Biomaterials for Bone Tissue Engineering.
Dec P, Modrzejewski A, Pawlik A Int J Mol Sci. 2023; 24(1).
PMID: 36613972 PMC: 9820083. DOI: 10.3390/ijms24010529.